6/17/2022 9:09:12 AM
Sana : Data Shows Survival Of Transplanted Hypoimmune IPSC-Derived Differentiated Cell Types
3/16/2022 8:37:37 AM
Sana Biotechnology Q4 Net Loss $110.7 Mln Or $0.60/Shr Vs Loss $113.2 Mln Or $7.40/Shr Last Year
8/9/2021 2:22:04 AM
MaxCyte Signs Clinical And Commercial License With Sana Biotechnology